These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 18166995)

  • 1. Photons or protons: precision radiotherapy of lung cancer.
    Auberger T; Seydl K; Futschek T; Sztankay A; Sweeney RA; Lukas P
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():3-6. PubMed ID: 18166995
    [No Abstract]   [Full Text] [Related]  

  • 2. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
    Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
    St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
    Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
    Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases.
    Yartsev S; Chen J; Yu E; Kron T; Rodrigues G; Coad T; Trenka K; Wong E; Bauman G; Dyk JV
    Radiother Oncol; 2006 Feb; 78(2):169-76. PubMed ID: 16413621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation treatment of lung cancer].
    Hayakawa K
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1211-4. PubMed ID: 17847583
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
    Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
    J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative radiotherapy for lung cancer: improvement in locoregional control using three-dimensional compared with two-dimensional technique.
    Masson-Côté L; Couture C; Fortin A; Dagnault A
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):686-91. PubMed ID: 20646845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can protons improve SBRT for lung lesions? Dosimetric considerations.
    Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
    Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non small cell lung cancer].
    Leignel Argo D; Giraud P
    Cancer Radiother; 2010 Nov; 14 Suppl 1():S61-73. PubMed ID: 21129672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
    Siedschlag C; Boersma L; van Loon J; Rossi M; van Baardwijk A; Gilhuijs K; Stroom J
    Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?
    Jeremic B
    Radiother Oncol; 2004 May; 71(2):123-5. PubMed ID: 15110444
    [No Abstract]   [Full Text] [Related]  

  • 16. Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Weisenburger TH; Graham MV; Sause WT; Byhardt RW; Curran WJ; Fuller D; Ko B; Komaki R; Kaiser LR; Leibel SA
    Radiology; 2000 Jun; 215 Suppl():1295-318. PubMed ID: 11037548
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
    Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
    Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curative radiotherapy of local advanced non-small-cell lung cancer. Eight years of experience from Odense].
    Hansen O; Paarup H; Sørensen P; Hansen KH; Werenberg KA
    Ugeskr Laeger; 2005 Sep; 167(37):3497-502. PubMed ID: 16159459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of forward planning with automated inverse planning for three-dimensional conformal radiotherapy of non-small cell lung cancer without IMRT.
    Mendes R; Lavrenkov K; Bedford JL; Henrys A; Ashley S; Brada M
    Radiother Oncol; 2006 Mar; 78(3):322-5. PubMed ID: 16564591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.